Euglycemic diabetic ketoacidosis in pregnancy with COVID-19: A case report and literature review

Clin Case Rep. 2022 Apr 5;10(4):e05680. doi: 10.1002/ccr3.5680. eCollection 2022 Apr.

Abstract

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes and is considered a medical emergency. Euglycemic DKA (EKDA) is a variant of DKA with a normal or minimally elevated glucose level <200 mg/dl. The condition can be difficult to diagnose due to the relatively normal glucose levels. Pregnancy, infection, and a low-calorie intake are some of the contributing common etiologies of EDKA. Despite a rapid increase in scientific publications on COVID-19, there are still knowledge gaps regarding the course of COVID-19 in some patient subset. This is especially the case for pregnant women. In this case report, we discuss the course of COVID-19 infection in a pregnant woman with gestational diabetes who developed severe euglycemic diabetic ketoacidosis triggered by various precipitating factors, including starvation, caused by COVID-19 infection and its gastrointestinal effects.

Keywords: COVID‐19 infection; euglycemic diabetic ketoacidosis; pregnancy.

Publication types

  • Case Reports